Combining CAR-T cells and inhibitor drugs for high-risk neuroblastoma medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
Despite an overall positive safety outlook, the scope of potential toxicities related to chimeric antigen receptor T-cell therapy remains unclear due to lack of long-term follow-up.It has been barely a decade since the modality produced the first reported remission in a child with B-cell acute lymphoblastic leukemia.